HIN 0.00% $2.37 heartware international, inc

htwr concerns...... says wedbush.

  1. 228 Posts.
    HeartWare concerns create buying opportunity, says Wedbush
    Wedbush believes concerns surrounding HeartWare's HVAD Pump are tied to unfounded rumors and creates a buying opportunity into the name. The firm does not see evidence of unusual clotting patters with the HVAD and reiterates an Outperform rating on HeartWare shares. :theflyonthewall.com

    ***********
    Thoratec up to its dirty tricks again??
 
watchlist Created with Sketch. Add HIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.